Dire Warning on Diabetes Drug

Byetta competes against blockbuster drugs from GlaxoSmithKline PLC and Takeda Pharmaceuticals in the $24 billion global market for diabetes medications, according to health care research firm IMS Health. ...

Posted in Diabetes medications  on Wed, 20 Aug 2008 04:01:40 -0700
Tags:
Original article: Dire Warning on Diabetes Drug by at diabetes medications - Google Blog Search